Alan Brochstein, CFA
Contrarian, growth at reasonable price, management change, cannabis stocks

GW Pharma: Capitalizing On Cannabis Science

GW Pharma (NASDAQ:GWPH) is a NASDAQ-traded biotech based in the UK with a primary listing on the London Stock Exchange (GWP is the symbol). After trading quietly for months following its May 1st IPO, the stock has more than tripled. Though it has traded publicly since 2001 without much success, the recent move following an analyst upgrade and dramatic target hike pushed the stock to a multi-year high. The move earlier this year to gain a U.S. listing was brilliant, as it has expanded the investor base and more than doubled its analyst following. GW has done a lot of things correctly in my view, and it is poised to benefit from increased investor awareness of its opportunities....

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details